1. Home
  2. GLSI vs HAIN Comparison

GLSI vs HAIN Comparison

Compare GLSI & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLSI
  • HAIN
  • Stock Information
  • Founded
  • GLSI 2006
  • HAIN 1993
  • Country
  • GLSI United States
  • HAIN United States
  • Employees
  • GLSI N/A
  • HAIN N/A
  • Industry
  • GLSI Biotechnology: Pharmaceutical Preparations
  • HAIN Packaged Foods
  • Sector
  • GLSI Health Care
  • HAIN Consumer Staples
  • Exchange
  • GLSI Nasdaq
  • HAIN Nasdaq
  • Market Cap
  • GLSI 149.5M
  • HAIN 159.7M
  • IPO Year
  • GLSI 2020
  • HAIN 1993
  • Fundamental
  • Price
  • GLSI $11.53
  • HAIN $1.52
  • Analyst Decision
  • GLSI Strong Buy
  • HAIN Hold
  • Analyst Count
  • GLSI 1
  • HAIN 9
  • Target Price
  • GLSI $39.00
  • HAIN $3.85
  • AVG Volume (30 Days)
  • GLSI 57.0K
  • HAIN 1.5M
  • Earning Date
  • GLSI 11-13-2025
  • HAIN 09-15-2025
  • Dividend Yield
  • GLSI N/A
  • HAIN N/A
  • EPS Growth
  • GLSI N/A
  • HAIN N/A
  • EPS
  • GLSI N/A
  • HAIN N/A
  • Revenue
  • GLSI N/A
  • HAIN $1,559,780,000.00
  • Revenue This Year
  • GLSI N/A
  • HAIN $0.33
  • Revenue Next Year
  • GLSI N/A
  • HAIN $1.02
  • P/E Ratio
  • GLSI N/A
  • HAIN N/A
  • Revenue Growth
  • GLSI N/A
  • HAIN N/A
  • 52 Week Low
  • GLSI $8.06
  • HAIN $1.30
  • 52 Week High
  • GLSI $15.50
  • HAIN $9.43
  • Technical
  • Relative Strength Index (RSI)
  • GLSI 51.82
  • HAIN 36.88
  • Support Level
  • GLSI $11.12
  • HAIN $1.42
  • Resistance Level
  • GLSI $13.00
  • HAIN $2.17
  • Average True Range (ATR)
  • GLSI 0.65
  • HAIN 0.13
  • MACD
  • GLSI -0.01
  • HAIN -0.03
  • Stochastic Oscillator
  • GLSI 40.66
  • HAIN 11.84

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: